Filing Flows › Comparisons › GERN vs ETON
Geron vs Eton Pharmaceuticals: GERN and ETON compared
Geron is the larger company: $60.2M of revenue in its latest quarter (Q3 2026) against $57.9M for Eton Pharmaceuticals (Q3 2026). Eton Pharmaceuticals is growing faster (+158% against +27% a year earlier). Eton Pharmaceuticals is more profitable, with an operating margin of 39.7% against 9.6%.
Where the money goes: GERN and ETON
Geron (GERN) · Q3 2026
Geron, Q3 2026: revenue $60.2M (+27% year over year), operating margin 9.6%, net earnings $1.4M, operating cash flow $10.3M. The chart follows the revenue to costs, profit and cash.
Eton Pharmaceuticals (ETON) · Q3 2026
Eton Pharmaceuticals, Q3 2026: revenue $57.9M (+158% year over year), operating margin 39.7%, net earnings $35.2M, operating cash flow $35.2M. The chart follows the revenue to costs, profit and cash.
| Geron (GERN) | Eton Pharmaceuticals (ETON) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $60.2M | $57.9M |
| Revenue growth, Y/Y | +27% | +158% |
| Gross margin | — | 76.5% |
| Operating margin | 9.6% | 39.7% |
| Net earnings | $1.4M | $35.2M |
| Net margin | 2.2% | 60.9% |
| Operating cash flow | $10.3M | $35.2M |
| Free cash flow | — | $35.2M |
Questions
Which is bigger, Geron or Eton Pharmaceuticals?
Geron is the larger company: $60.2M of revenue in its latest quarter (Q3 2026) against $57.9M for Eton Pharmaceuticals (Q3 2026).
Is Geron or Eton Pharmaceuticals growing faster?
Eton Pharmaceuticals is growing faster (+158% against +27% a year earlier).
Which is more profitable, Geron or Eton Pharmaceuticals?
Eton Pharmaceuticals is more profitable, with an operating margin of 39.7% against 9.6%.
More: Geron earnings · how Geron makes money · Eton Pharmaceuticals earnings · how Eton Pharmaceuticals makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.